TG Therapeutics targets $525M BRIUMVI revenue in 2025 while advancing subcutaneous formulation and pivotal trials
Q4 2024 Management View CEO Michael Weiss highlighted the strong full-year 2024 U.S. revenue of $310 million for BRIUMVI, exceeding initial guidance and reflecting the therapy's value in treating ...
Waste Dive37m
Major public waste companies spent nearly $11B on M&A in 2024
WM drove major spending with its $7.2 billion Stericycle deal in 2024. Republic Services, Waste Connections, GFL ...
Ready Capital targets $1.5B SBA loan originations in 2025 with focus on small business growth
Q4 2024 Management View CEO Thomas Capasse stated that aggressive reserving on problem loans and a dividend reduction were pivotal actions to stabilize book value per share and dividend levels. The ...
Best Buy expected to report further declines in fourth quarter earnings as the chain braces for tariff impact
As of the third quarter, Best Buy projected 2024 same-store sales to decline 2.5% to 3.5%. That's compared to a previously expected decline of 1.5% to 3%. The Street expects Best Buy to end the year ...